Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 312

1.

Human iPSC modeling of a familial form of atrial fibrillation reveals a gain of function of If and ICaL in patient-derived cardiomyocytes.

Benzoni P, Campostrini G, Landi S, Bertini V, Marchina E, Iascone M, Ahlberg G, Olesen MS, Crescini E, Mora C, Bisleri G, Muneretto C, Ronca R, Presta M, Poliani PL, Piovani G, Verardi R, Pasquale ED, Consiglio A, Raya A, Torre E, Lodrini AM, Milanesi R, Rocchetti M, Baruscotti M, DiFrancesco D, Memo M, Barbuti A, Dell'Era P.

Cardiovasc Res. 2019 Aug 28. pii: cvz217. doi: 10.1093/cvr/cvz217. [Epub ahead of print]

PMID:
31504264
2.

The Autocrine FGF/FGFR System in both Skin and Uveal Melanoma: FGF Trapping as a Possible Therapeutic Approach.

Rezzola S, Ronca R, Loda A, Nawaz MI, Tobia C, Paganini G, Maccarinelli F, Giacomini A, Semeraro F, Mor M, Presta M.

Cancers (Basel). 2019 Sep 4;11(9). pii: E1305. doi: 10.3390/cancers11091305.

3.

Long Pentraxin-3 Follows and Modulates Bladder Cancer Progression.

Matarazzo S, Melocchi L, Rezzola S, Grillo E, Maccarinelli F, Giacomini A, Turati M, Taranto S, Zammataro L, Cerasuolo M, Bugatti M, Vermi W, Presta M, Ronca R.

Cancers (Basel). 2019 Aug 30;11(9). pii: E1277. doi: 10.3390/cancers11091277.

4.

VEGFR2 activation mediates the pro-angiogenic activity of BMP4.

Rezzola S, Di Somma M, Corsini M, Leali D, Ravelli C, Polli VAB, Grillo E, Presta M, Mitola S.

Angiogenesis. 2019 Jul 30. doi: 10.1007/s10456-019-09676-y. [Epub ahead of print]

PMID:
31363885
5.

Vascular Endothelial Growth Factor in the Vitreous of Proliferative Diabetic Retinopathy Patients: Chasing a Hiding Prey?

Rezzola S, Nawaz MI, Cancarini A, Semeraro F, Presta M.

Diabetes Care. 2019 Jul;42(7):e105-e106. doi: 10.2337/dc18-2527. Epub 2019 May 21. No abstract available.

PMID:
31221704
6.

Atypical Chemokine Receptor 3 Generates Guidance Cues for CXCL12-Mediated Endothelial Cell Migration.

Tobia C, Chiodelli P, Barbieri A, Buraschi S, Ferrari E, Mitola S, Borsani G, Guerra J, Presta M.

Front Immunol. 2019 May 15;10:1092. doi: 10.3389/fimmu.2019.01092. eCollection 2019.

7.

Quantification of 3D Brain Microangioarchitectures in an Animal Model of Krabbe Disease.

Righi M, Belleri M, Presta M, Giacomini A.

Int J Mol Sci. 2019 May 14;20(10). pii: E2384. doi: 10.3390/ijms20102384.

8.

Circulating microRNAs and Their Role in Multiple Myeloma.

Federico C, Sacco A, Belotti A, Ribolla R, Cancelli V, Giacomini A, Ronca R, Chiarini M, Imberti L, Marini M, Rossi G, Presta M, Paiva B, Roccaro AM.

Noncoding RNA. 2019 May 2;5(2). pii: E37. doi: 10.3390/ncrna5020037. Review.

9.

Human vitreous in proliferative diabetic retinopathy: Characterization and translational implications.

Nawaz IM, Rezzola S, Cancarini A, Russo A, Costagliola C, Semeraro F, Presta M.

Prog Retin Eye Res. 2019 Sep;72:100756. doi: 10.1016/j.preteyeres.2019.03.002. Epub 2019 Apr 2. Review.

PMID:
30951889
10.

Response to ASA and ESA fasting guidelines are not in concert.

Presta MV, Bhavani SS, Abdelmalak BB.

Minerva Anestesiol. 2019 Jul;85(7):800-801. doi: 10.23736/S0375-9393.19.13630-9. Epub 2019 Mar 12. No abstract available.

11.

Zebrafish disease models in hematology: Highlights on biological and translational impact.

Zizioli D, Mione M, Varinelli M, Malagola M, Bernardi S, Alghisi E, Borsani G, Finazzi D, Monti E, Presta M, Russo D.

Biochim Biophys Acta Mol Basis Dis. 2019 Mar 1;1865(3):620-633. doi: 10.1016/j.bbadis.2018.12.015. Epub 2018 Dec 26. Review.

PMID:
30593895
12.

Vascular amounts and dispersion of caliber-classified vessels as key parameters to quantitate 3D micro-angioarchitectures in multiple myeloma experimental tumors.

Righi M, Locatelli SL, Carlo-Stella C, Presta M, Giacomini A.

Sci Rep. 2018 Nov 30;8(1):17520. doi: 10.1038/s41598-018-35788-4.

13.

Long Pentraxin 3-Mediated Fibroblast Growth Factor Trapping Impairs Fibrosarcoma Growth.

Rodrigues PF, Matarazzo S, Maccarinelli F, Foglio E, Giacomini A, Silva Nunes JP, Presta M, Dias AAM, Ronca R.

Front Oncol. 2018 Nov 1;8:472. doi: 10.3389/fonc.2018.00472. eCollection 2018.

14.

Nil per os guidelines: what is changing, what is not, and what should?

Presta MV, Bhavani SS, Abdelmalak BB.

Minerva Anestesiol. 2018 Dec;84(12):1413-1419. doi: 10.23736/S0375-9393.18.13042-2. Epub 2018 Oct 30.

15.

Long Pentraxin-3 Modulates the Angiogenic Activity of Fibroblast Growth Factor-2.

Presta M, Foglio E, Churruca Schuind A, Ronca R.

Front Immunol. 2018 Oct 8;9:2327. doi: 10.3389/fimmu.2018.02327. eCollection 2018. Review.

16.

Editorial overview: Lymphatic vessels: More than a draining pipeline.

Presta M, Sozzani S.

Curr Opin Immunol. 2018 Aug;53:vii-ix. doi: 10.1016/j.coi.2018.08.004. No abstract available.

PMID:
30220353
17.

Future applications of FGF/FGFR inhibitors in cancer.

Ghedini GC, Ronca R, Presta M, Giacomini A.

Expert Rev Anticancer Ther. 2018 Sep;18(9):861-872. doi: 10.1080/14737140.2018.1491795. Epub 2018 Jul 2. Review.

PMID:
29936878
18.

Dendritic cells in inflammatory angiogenesis and lymphangiogenesis.

Bosisio D, Ronca R, Salvi V, Presta M, Sozzani S.

Curr Opin Immunol. 2018 Aug;53:180-186. doi: 10.1016/j.coi.2018.05.011. Epub 2018 Jun 4. Review.

PMID:
29879585
19.

Claudin3 is localized outside the tight junctions in human carcinomas.

Corsini M, Ravaggi A, Odicino F, Santin AD, Ravelli C, Presta M, Romani C, Mitola S.

Oncotarget. 2018 Apr 6;9(26):18446-18453. doi: 10.18632/oncotarget.24858. eCollection 2018 Apr 6.

20.

Long pentraxin 3: A novel multifaceted player in cancer.

Giacomini A, Ghedini GC, Presta M, Ronca R.

Biochim Biophys Acta Rev Cancer. 2018 Jan;1869(1):53-63. doi: 10.1016/j.bbcan.2017.11.004. Epub 2017 Nov 23. Review.

PMID:
29175552
21.

Fibroblast growth factor modulates mast cell recruitment in a murine model of prostate cancer.

Ronca R, Tamma R, Coltrini D, Ruggieri S, Presta M, Ribatti D.

Oncotarget. 2017 Aug 1;8(47):82583-82592. doi: 10.18632/oncotarget.19773. eCollection 2017 Oct 10.

22.

N-tert-butyloxycarbonyl-Phe-Leu-Phe-Leu-Phe (BOC2) inhibits the angiogenic activity of heparin-binding growth factors.

Nawaz IM, Chiodelli P, Rezzola S, Paganini G, Corsini M, Lodola A, Di Ianni A, Mor M, Presta M.

Angiogenesis. 2018 Feb;21(1):47-59. doi: 10.1007/s10456-017-9581-6. Epub 2017 Oct 13.

PMID:
29030736
23.

3D endothelial cell spheroid/human vitreous humor assay for the characterization of anti-angiogenic inhibitors for the treatment of proliferative diabetic retinopathy.

Rezzola S, Nawaz IM, Cancarini A, Ravelli C, Calza S, Semeraro F, Presta M.

Angiogenesis. 2017 Nov;20(4):629-640. doi: 10.1007/s10456-017-9575-4. Epub 2017 Sep 13.

PMID:
28905243
24.

Contribution of vascular endothelial growth factor receptor-2 sialylation to the process of angiogenesis.

Chiodelli P, Rezzola S, Urbinati C, Federici Signori F, Monti E, Ronca R, Presta M, Rusnati M.

Oncogene. 2017 Nov 23;36(47):6531-6541. doi: 10.1038/onc.2017.243. Epub 2017 Aug 7.

PMID:
28783175
25.

Fibroblast growth factors (FGFs) in cancer: FGF traps as a new therapeutic approach.

Presta M, Chiodelli P, Giacomini A, Rusnati M, Ronca R.

Pharmacol Ther. 2017 Nov;179:171-187. doi: 10.1016/j.pharmthera.2017.05.013. Epub 2017 May 28. Review.

PMID:
28564583
26.

U94 of human herpesvirus 6 down-modulates Src, promotes a partial mesenchymal-to-epithelial transition and inhibits tumor cell growth, invasion and metastasis.

Caccuri F, Ronca R, Laimbacher AS, Berenzi A, Steimberg N, Campilongo F, Mazzuca P, Giacomini A, Mazzoleni G, Benetti A, Caselli E, Presta M, Di Luca D, Fraefel C, Caruso A.

Oncotarget. 2017 Jul 4;8(27):44533-44549. doi: 10.18632/oncotarget.17817.

27.

The importance of the genomic landscape in Waldenström's Macroglobulinemia for targeted therapeutical interventions.

Sacco A, Fenotti A, Affò L, Bazzana S, Russo D, Presta M, Malagola M, Anastasia A, Motta M, Patterson CJ, Rossi G, Imberti L, Treon SP, Ghobrial IM, Roccaro AM.

Oncotarget. 2017 May 23;8(21):35435-35444. doi: 10.18632/oncotarget.16130. Review.

28.

Inflammation and N-formyl peptide receptors mediate the angiogenic activity of human vitreous humour in proliferative diabetic retinopathy.

Rezzola S, Corsini M, Chiodelli P, Cancarini A, Nawaz IM, Coltrini D, Mitola S, Ronca R, Belleri M, Lista L, Rusciano D, De Rosa M, Pavone V, Semeraro F, Presta M.

Diabetologia. 2017 Apr;60(4):719-728. doi: 10.1007/s00125-016-4204-0. Epub 2017 Jan 13.

PMID:
28083635
29.

Endoscopic Laser Management of a Leiomyoma of the Left Main Stem Bronchus.

Bakhos C, Stavrakis C, Presta M.

J Bronchology Interv Pulmonol. 2017 Jan;24(1):e14-e16. No abstract available.

PMID:
27984395
30.

Synthetic Site-Selectively Mono-6-O-Sulfated Heparan Sulfate Dodecasaccharide Shows Anti-Angiogenic Properties In Vitro and Sensitizes Tumors to Cisplatin In Vivo.

Avizienyte E, Cole CL, Rushton G, Miller GJ, Bugatti A, Presta M, Gardiner JM, Jayson GC.

PLoS One. 2016 Aug 4;11(8):e0159739. doi: 10.1371/journal.pone.0159739. eCollection 2016.

31.

Evaluation of the Biotoxicity of Tree Wood Ashes in Zebrafish Embryos.

Consigli V, Guarienti M, Bilo F, Benassi L, Depero LE, Bontempi E, Presta M.

Zebrafish. 2016 Oct;13(5):449-55. doi: 10.1089/zeb.2016.1255. Epub 2016 Aug 3.

PMID:
27487527
32.

Monomeric gremlin is a novel vascular endothelial growth factor receptor-2 antagonist.

Grillo E, Ravelli C, Corsini M, Ballmer-Hofer K, Zammataro L, Oreste P, Zoppetti G, Tobia C, Ronca R, Presta M, Mitola S.

Oncotarget. 2016 Jun 7;7(23):35353-68. doi: 10.18632/oncotarget.9286.

33.

COSMOS-rice technology abrogates the biotoxic effects of municipal solid waste incinerator residues.

Guarienti M, Cardozo SM, Borgese L, Lira GR, Depero LE, Bontempi E, Presta M.

Environ Pollut. 2016 Jul;214:713-721. doi: 10.1016/j.envpol.2016.04.053. Epub 2016 May 3.

PMID:
27149148
34.

Synthesis, Structural Elucidation, and Biological Evaluation of NSC12, an Orally Available Fibroblast Growth Factor (FGF) Ligand Trap for the Treatment of FGF-Dependent Lung Tumors.

Castelli R, Giacomini A, Anselmi M, Bozza N, Vacondio F, Rivara S, Matarazzo S, Presta M, Mor M, Ronca R.

J Med Chem. 2016 May 26;59(10):4651-63. doi: 10.1021/acs.jmedchem.5b02021. Epub 2016 May 3.

PMID:
27138345
35.

Zebrafish (Danio rerio) embryo as a platform for the identification of novel angiogenesis inhibitors of retinal vascular diseases.

Rezzola S, Paganini G, Semeraro F, Presta M, Tobia C.

Biochim Biophys Acta. 2016 Jul;1862(7):1291-6. doi: 10.1016/j.bbadis.2016.04.009. Epub 2016 Apr 13. Review.

36.

Assessment and Molecular Characterization of Human Intestinal Parasites in Bivalves from Orchard Beach, NY, USA.

Tei FF, Kowalyk S, Reid JA, Presta MA, Yesudas R, Mayer DC.

Int J Environ Res Public Health. 2016 Mar 29;13(4):381. doi: 10.3390/ijerph13040381.

37.

Endothelial cell dysfunction in globoid cell leukodystrophy.

Belleri M, Presta M.

J Neurosci Res. 2016 Nov;94(11):1359-67. doi: 10.1002/jnr.23744. Epub 2016 Apr 1. Review.

PMID:
27037626
38.

Blocking the FGF/FGFR system as a "two-compartment" antiangiogenic/antitumor approach in cancer therapy.

Giacomini A, Chiodelli P, Matarazzo S, Rusnati M, Presta M, Ronca R.

Pharmacol Res. 2016 May;107:172-185. doi: 10.1016/j.phrs.2016.03.024. Epub 2016 Mar 22. Review.

PMID:
27013279
39.

A tool for the quantification of radial neo-vessels in chick chorioallantoic membrane angiogenic assays.

Gnutti A, Signoroni A, Leonardi R, Corsini M, Presta M, Mitola S.

Conf Proc IEEE Eng Med Biol Soc. 2015 Aug;2015:763-6. doi: 10.1109/EMBC.2015.7318474.

PMID:
26736374
40.

SIGMAR1 Regulates Membrane Electrical Activity in Response to Extracellular Matrix Stimulation to Drive Cancer Cell Invasiveness.

Crottès D, Rapetti-Mauss R, Alcaraz-Perez F, Tichet M, Gariano G, Martial S, Guizouarn H, Pellissier B, Loubat A, Popa A, Paquet A, Presta M, Tartare-Deckert S, Cayuela ML, Martin P, Borgese F, Soriani O.

Cancer Res. 2016 Feb 1;76(3):607-18. doi: 10.1158/0008-5472.CAN-15-1465. Epub 2015 Dec 8.

41.

Brain angioarchitecture and intussusceptive microvascular growth in a murine model of Krabbe disease.

Giacomini A, Ackermann M, Belleri M, Coltrini D, Nico B, Ribatti D, Konerding MA, Presta M, Righi M.

Angiogenesis. 2015 Oct;18(4):499-510. doi: 10.1007/s10456-015-9481-6. Epub 2015 Aug 27.

PMID:
26310512
42.

β3 Integrin Promotes Long-Lasting Activation and Polarization of Vascular Endothelial Growth Factor Receptor 2 by Immobilized Ligand.

Ravelli C, Grillo E, Corsini M, Coltrini D, Presta M, Mitola S.

Arterioscler Thromb Vasc Biol. 2015 Oct;35(10):2161-71. doi: 10.1161/ATVBAHA.115.306230. Epub 2015 Aug 20.

43.

Long-Pentraxin 3 Derivative as a Small-Molecule FGF Trap for Cancer Therapy.

Ronca R, Giacomini A, Di Salle E, Coltrini D, Pagano K, Ragona L, Matarazzo S, Rezzola S, Maiolo D, Torrella R, Moroni E, Mazzieri R, Escobar G, Mor M, Colombo G, Presta M.

Cancer Cell. 2015 Aug 10;28(2):225-39. doi: 10.1016/j.ccell.2015.07.002.

44.

Revenue from single-balloon enteroscopy is driven by anesthesia: experience from a tertiary care facility.

Banerjee N, Presta M, Charous M, Gupta N.

Surg Endosc. 2016 Apr;30(4):1635-9. doi: 10.1007/s00464-015-4394-4. Epub 2015 Jul 14.

PMID:
26169643
45.

The potential of fibroblast growth factor/fibroblast growth factor receptor signaling as a therapeutic target in tumor angiogenesis.

Ronca R, Giacomini A, Rusnati M, Presta M.

Expert Opin Ther Targets. 2015;19(10):1361-77. doi: 10.1517/14728222.2015.1062475. Epub 2015 Jun 30. Review.

PMID:
26125971
46.

A long pentraxin-3-derived pentapeptide for the therapy of FGF8b-driven steroid hormone-regulated cancers.

Giacomini A, Matarazzo S, Pagano K, Ragona L, Rezzola S, Corsini M, Di Salle E, Presta M, Ronca R.

Oncotarget. 2015 May 30;6(15):13790-802.

47.

Antiangiogenic Effectiveness of the Urokinase Receptor-Derived Peptide UPARANT in a Model of Oxygen-Induced Retinopathy.

Dal Monte M, Rezzola S, Cammalleri M, Belleri M, Locri F, Morbidelli L, Corsini M, Paganini G, Semeraro F, Cancarini A, Rusciano D, Presta M, Bagnoli P.

Invest Ophthalmol Vis Sci. 2015 Apr;56(4):2392-407. doi: 10.1167/iovs.14-16323.

PMID:
25766585
48.

Therapeutic Potential of Anti-Angiogenic Multitarget N,O-Sulfated E. Coli K5 Polysaccharide in Diabetic Retinopathy.

Rezzola S, Dal Monte M, Belleri M, Bugatti A, Chiodelli P, Corsini M, Cammalleri M, Cancarini A, Morbidelli L, Oreste P, Bagnoli P, Semeraro F, Presta M.

Diabetes. 2015 Jul;64(7):2581-92. doi: 10.2337/db14-1378. Epub 2015 Feb 18.

49.

The broad-spectrum anti-DNA virus agent cidofovir inhibits lung metastasis of virus-independent, FGF2-driven tumors.

Liekens S, Noppen S, Gijsbers S, Sienaert R, Ronca R, Tobia C, Presta M.

Oncotarget. 2015 Mar 10;6(7):4633-48.

50.

Zebrafish embryo intersegmental vessels: a tool for investigating sprouting angiogenesis.

Tobia C, Gariano G, Guerra J, Presta M.

Methods Mol Biol. 2015;1214:173-84. doi: 10.1007/978-1-4939-1462-3_10.

PMID:
25468604

Supplemental Content

Loading ...
Support Center